- GlucoseGlucose: In rats, treatment with L-carnitine reduced plasma glucose (105). In healthy volunteers, carnitine was able to reduce the increase in plasma glucose levels induced by glucose infusion (124). Decreased glucose was noted in diabetic individuals given L-carnitine (6).
- LipidsLipids: Carnitine was reported to reduce the level of serum triglycerides in patients with hyperlipidemia (129; 130). Decreased triglycerides were also found in infants (102; 115) and other populations (9; 11; 131; 20; 132; 123). Decreased cholesterol has been noted (9; 133; 131; 20). Decreased total cholesterol to HDL cholesterol ratio has been noted (134; 135). Use of a new lipid emulsion containing carnitine, in infants, resulted in a decrease in DHA and arachidonic acid (AA) (113). A decrease in free fatty acids has been noted in patients with coronary artery disease and in top athletes (122; 123).
- PhosphorousPhosphorous: A slight decrease has been noted in hemodialysis patients (120).
Copyright © 2011 Natural Standard (www.naturalstandard.com)
The information in this monograph is intended for informational purposes only, and is meant to help users better understand health concerns. Information is based on review of scientific research data, historical practice patterns, and clinical experience. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions.